Trial Profile
A study assessing characteristics of everolimus receiving post-menopausal female patients with HR+/HER2- metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jul 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 09 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.